Latest News
From the Journals
Survival in the first 3 years of ART continues to improve
Survival of persons with HIV-1 infections taking ART continues to improve.
From the Journals
Deep infiltrating endometriosis lesions harbor cancer-driver mutations
A finding of cancer-related mutations in noncancerous lesions is “surprising” and raises new questions about the pathobiology of endometriosis.
Feature
Do you have to MIPS in 2017? CMS has a tool for that
A Web tool from CMS allows physicians to quickly know if they must participate in the Merit-based Incentive Payment System this year.
Conference Coverage
PPIs triple heart failure hospitalization risk in atrial fib patients
PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart...
Conference Coverage
Misoprostol effective in healing aspirin-induced small bowel bleeding
Misoprostol was more effective than placebo in healing small bowel ulcers in patients who used daily low-dose aspirin.
Law & Medicine
Determining patients’ decisional capacity
When do patients no longer have the medical capacity to make their own health care decisions, and when can surrogates make those decisions for...
From the Journals
Muscle-related AEs reported in statin trial suggest ‘nocebo’ effect
Patients taking placebo reported more muscle-related adverse events during the blinded phase of the ASCOT-LLA trial than in the nonblinded portion...
Conference Coverage
More than one-third of genetic tests misordered, study finds
SAN DIEGO – The results are a call to action for ob.gyns. to get training on appropriate ordering of genetic tests.
From the Journals
Adult vaccination is low, with minimal improvement in recent years
Only minimal improvement in adult vaccination coverage has been made in recent years.
Conference Coverage
Consider strongyloidiasis before giving oral steroids
Strongyloides stercoralis infection can flare dramatically when patients take oral steroids.
Conference Coverage
Dalbavancin proves highly effective in osteomyelitis
VIENNA – Preliminary results of a phase II trial show that the long-acting lipoglycopeptide antibiotic dalbavancin cleared infection in 100% of...